Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Federico Bolcic"'
Publikováno v:
Acta Gastroenterológica Latinoamericana, Vol 38, Iss 4, Pp 307-308 (2008)
Externí odkaz:
https://doaj.org/article/217dd2eab4a341468cf43e0e1f06eadb
Autor:
Maximilian Bönisch, Matthias Wieser, Regina Grillari-Voglauer, Harald Kühnel, Rita Reynoso, Jorge Quarleri, Heribert Quendler, Johannes Grillari, Diego Sebastian Ojeda, Federico Bolcic
Publikováno v:
Journal of Virology. 86:10327-10337
Monocyte-derived macrophages (MDM) are widely distributed in all tissues and organs, including the central nervous system, where they represent the main part of HIV-infected cells. In contrast to activated CD4 + T lymphocytes, MDM are resistant to cy
Autor:
Rita Reynoso, Jorge Quarleri, Natalia Laufer, Lucila Cassino, Carolina Torres, Federico Bolcic
Publikováno v:
Antiviral Research. 95:72-81
The rate of non-response to pegylated interferon plus ribavirin (peg-IFN+RBV) in HCV/HIV coinfected patients is higher than in HCV-monoinfected patients. In this sense, the contribution of HCV genetic variability is unknown. The 5' untranslated (5'UT
Publikováno v:
Journal of Medical Virology. 83:935-940
The prevalence of hepatitis C virus genotype 4 (HCV-4) is increasing in different parts of the World but in Latin America the data are still scarce. We aimed to characterize HCV-4 isolates from 383 HIV-coinfected patients in Argentina. Sequence analy
Autor:
Horacio Salomón, Natalia Laufer, Ana de Dios Martínez, P. Cahn, Federico Bolcic, Rita Reynoso, Héctor Pérez, Jorge Quarleri, María José Rolón
Publikováno v:
Antiviral Research. 90:92-97
Treatment with Peg-interferon and ribavirin (PEG-IFN/RBV) for HIV patients co-infected with hepatitis C virus (HCV) genotype 1 has suboptimal rates of response. Viral kinetics has emerged as one of the best prognostic factors of treatment outcome.Twe
Autor:
Federico Bolcic, Franco Moretti, María Belén Bouzas, Jorge Quarleri, Natalia Laufer, Lilia Mammana
Publikováno v:
AIDS Research and Human Retroviruses. 26:527-532
Fil: Moretti, Franco. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Microbiología. Area Virologia; Argentina Fil: Bolcic, Federico Martin. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de B
Autor:
Federico Bolcic, L. Martinez, Jorge Quarleri, Rita Reynoso, Lara M. Bull, Horacio Salomón, Roberto C. Arduino, Ben J. Barnett
Publikováno v:
Intervirology. 51:261-264
Autor:
L. Abusamra, Pedro Cahn, M.J. Rolon, Jorge Quarleri, Alejandro J. Krolewiecki, Natalia Laufer, H. Pérez, Federico Bolcic, A. Gun, Horacio Salomón
Publikováno v:
Antiviral Research. 92:497-499
There are two new drugs approved and several in development for treatment of chronic HCV; among them nitazoxanide (NTZ). Twelve HIV/HCV genotype 1 co-infected patients were enrolled prospectively to receive a 30 days course of oral NTZ 500 mg bid. Th
Autor:
Mauricio, Carobene, Federico, Bolcic, María Sol Dos Ramos, Farías, Jorge, Quarleri, María Mercedes, Avila
Publikováno v:
Journal of medical virology. 86(1)
Commercial sex work is frequent among male-to-female transvestites, transsexuals and transgenders in Argentina, leading to high susceptibility to HIV, HBV, and HCV among other sexually transmitted infections. In a global context of scarce data on the
Publikováno v:
Journal of medical virology. 84(4)
The human immunodeficiency virus (HIV) and hepatitis C virus (HCV) share the same transmission routes which lead to high coinfection rates. Among HIV-infected individuals such rates reached 21% in Argentina, being HCV-1a the most predominant subtype.